Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Respiratory Tract
31. July 2026
Search
medline.ch
Respiratory Tract
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 8048
Articles 1 - 20 / 160949
Comprehensive Patient Reported Outcomes (PROs) from NRG Oncology/Alliance LU005: A Randomized Trial Of Chemoradiation +/- Atezolizumab In Limited-Stage Small Cell Lung Cancer.
J Thorac Oncol
Movsas B, Hu C, Higgins KA, Ross HJ, Jabbour SK, Kozono D, Owonikoko TK, Xiao C, Shoji T, Faller BA, Mohindra P, Dib EG, Brownstein J, Chun SG, Kuzma CS, Kotecha R, Onitilo A, Mulford D, Paulus R, Bradley JD, Bruner DW.
PMID: 42532339 [PubMed - as supplied by publisher]
Health-Related Quality of Life and Utility Values in Chinese Patients with Non-Small-Cell Lung Cancer: A Multicenter Study.
Value Health
Wang L, Guan X, Wang Y, Hu B, Xie F, Jin X, Li H, NSCLC Survey Group.
PMID: 42532266 [PubMed - as supplied by publisher]
Aptasensors for lung cancer detection.
Talanta
He L, Zhao X, Zhang X, Chen Z, Deng Y, Li S, He N, Liu Y.
PMID: 42531972 [PubMed - as supplied by publisher]
Efficacy and safety of immune checkpoint inhibitors in lung cancer patients with hepatitis B surface antigen positivity: a real-world cohort study.
Lung Cancer
Zhou X, Feng Y, Liang J, Bi X, Zhong Q, Xue L, Wang J, He J, Liu L, Cheng B, Liang W.
PMID: 42531850 [PubMed - as supplied by publisher]
Predictive value of peripheral blood hsa-miR-122-5p and hsa-miR-486-5p for response to neoadjuvant chemoimmunotherapy in lung squamous cell carcinoma.
Transl Oncol
Li G, Cheng X, Su C, Liu Z, Wen T, Ma T.
PMID: 42531729 [PubMed - as supplied by publisher]
Treatment patterns and outcomes of second/third-line therapy in advanced non-small cell lung cancer with actionable genomic alterations (RECAP).
Clin Exp Metastasis
Chen H, Meng X, Cai L, Lei W, Tang Y, Shi X, Ma L, Zhao J.
PMID: 42530663 [PubMed - indexed for MEDLINE]
Factors influencing participation in lung cancer screening among screening-eligible adults: a scoping review.
Prev Med Rep
Schneider C, Bosso L, Gros L, Durand MA, Selby K, L-Factors Study Group.
PMID: 42529670 [PubMed]
Diagnostic and surgical challenges of pulmonary mucoepidermoid carcinoma: a case report.
J Surg Case Rep
Arroyave-Guerrero Y, Giraldo-Cadavid LF, Garzón JC, Tellez LJ, Ariza Traslaviña JA, Viola L, Páez-Espinel N.
PMID: 42529626 [PubMed]
Specific PET Imaging for Precision Management of Lung Cancer: Advances, Clinical Translation and Future Directions.
Chem Biomed Imaging
Chen C, Pan D, Wang X, Xu Y, Yan J, Wang L, Yang M.
PMID: 42529427 [PubMed]
Efficacy of first-line treatment in driver gene-negative non-small cell lung cancer with liver metastases: a Bayesian network meta-analysis.
Front Immunol
Wu W, Guo X, Dong X, Liang H, Zhang L.
PMID: 42529281 [PubMed - indexed for MEDLINE]
Prognostic significance of extracapsular extension in patients with non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a retrospective cohort study.
Front Immunol
Qiu J, Li S, Ge L, Wang S, Hou X, Ling X.
PMID: 42528975 [PubMed - indexed for MEDLINE]
Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety.
Front Immunol
Quan Y, Liang Z, Wei Y, Li H, Zeng Y, Shen J, Su S, Liu X, Huang Z, Wang M, Luo H, Hu Y, Peng J.
PMID: 42528806 [PubMed - indexed for MEDLINE]
Distribution and function of human long-lasting T cells in aging and non-small cell lung cancer.
Front Immunol
Tan JX, Yu HR, Gu Y, Hong H.
PMID: 42528747 [PubMed - indexed for MEDLINE]
Research progress of small molecule targeted drugs for non-small cell lung cancer.
Front Oncol
Qiu T, Huang X.
PMID: 42528591 [PubMed]
Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience.
Future Oncol
Babel RA, Liu SV, Fan T, Amonkar MM, Velcheti V.
PMID: 42528479 [PubMed - as supplied by publisher]
Same Diagnosis, Different Disease: Why Sex Matters in Lung Cancer.
Respirology
Leong TL, Bonney A.
PMID: 42528283 [PubMed - as supplied by publisher]
The Optimal Lung Cancer Ct Screening Strategy: A Cost-Effectiveness Study Incorporating Nelson Evidence, Evolving Cost of Treatment and Smoking Cessation Interventions.
Int J Cancer
de Nijs K, Ten Haaf K, Moldovanu D, Hubert J, van den Bosch I, van der Aalst C, de Koning HJ.
PMID: 42528272 [PubMed - as supplied by publisher]
Harnessing Exhaled Breath for Lung Cancer Early Detection-Results From the ExPeL Study.
Clin Transl Sci
Patel DK, D'Cruz L, Ahmed W, Chauhan A, Bakerly ND, Grundy S, Trivedi DK, Knight S.
PMID: 42528019 [PubMed - indexed for MEDLINE]
The Importance of Driver-Targeted Therapy Among Patients With Lung Cancer Initially Diagnosed in the Intensive Care Unit.
Asia Pac J Clin Oncol
Hsiao YC, Ou WF, Lee PH, Hsu YW, Huang YH, Hsu KH, Tseng JS, Chang GC, Yang TY.
PMID: 42527842 [PubMed - as supplied by publisher]
Education and training in low-dose CT lung cancer screening across Europe: a survey study.
Insights Imaging
Mura R, Zolda P, Ledda RE, Baldwin DR, Hardavella G, Seijo L, Kerpel-Fronius A, Chorostowska-Wynimko J, Blum TG, Prosch H.
PMID: 42527752 [PubMed]
Articles 1 - 20 / 160949
Page 1 of 8048
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy